로딩 중…
지수 로딩 중…
Voyager Therapeutics Inc. Common Stock
VYGR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.13+4.17%
2026-08-04
Financials
Valuation Metrics
Voyager Therapeutics Inc. Common Stock's Market Cap is $189M. At end of 2025 it was $231M. Ranked #3037 of 3,112 in US market (top 98%), #1384 of 1,445 on NASDAQ (top 96%), #255 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 95%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $189M | US#3,037/3,112 Sec#255/269 |
| Revenue | $36M | US#2,883/3,112 Sec#164/269 |
| Net Income | $-117M | US—/3,112 Sec—/269 |
| Total Assets | $219M | US#2,965/3,112 Sec#246/269 |
| Net Assets | $174M | US#2,777/3,112 Sec#206/269 |
| Value | ||
| P/B | 1.09x | US#373/3,112 Sec#17/269 |
| P/S | 5.17x | US#2,263/3,112 Sec#79/269 |
| FCF Yield | -68.82% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -67.16% | US#2,795/3,112 Sec#197/269 |
| ROA | -53.18% | US#2,980/3,112 Sec#226/269 |
| Op. Margin | -349.16% | US#2,886/3,112 Sec#157/269 |
| Revenue Growth | -59.94% | US#2,891/3,112 Sec#166/269 |
| Financial Health | ||
| Debt Ratio | 26.29% | US#287/3,112 Sec#95/269 |
| Total Debt | $35M | US#2,616/3,112 Sec#162/269 |
| FCF | $-130M | US#2,643/3,112 Sec#173/269 |
| Cash | $43M | US#2,642/3,112 Sec#234/269 |
| Current Ratio | 8.42x | US#296/3,112 Sec#95/269 |
| Performance | ||
| 1Y Return | -2.65% | US#2,273/3,112 Sec#207/269 |
| 1M Return | -17.33% | US#2,956/3,112 Sec#235/269 |
| From 52W High | -43.69% | US#2,696/3,112 Sec#209/269 |
| 1Y MDD | -43.71% | US#2,144/3,112 Sec#160/269 |
| Trading | ||
| Volume | 393,892 shares | US#1,917/3,112 Sec#189/269 |
| Trading Value | $1M | US#2,939/3,112 Sec#246/269 |